Use of recombinant tissue plasminogen activator in cancer patients with acute stroke

Journal of Neuro-Oncology

Volumn 107, Issue 3, 2012, Pages 571-573

  Graber, Jerome J ^a   Nayak, Lakshmi ^a   DeAngelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer; Malignancy; Neoplasm; Recombinant tissue plasminogen activator; Stroke; TPA

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CARBOPLATIN; CARMUSTINE; FLUOROURACIL; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CENTER; CANCER PATIENT; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONVALESCENCE; DRUG CONTRAINDICATION; DRUG USE; FEMALE; GINGIVA BLEEDING; HUMAN; MALE; MELANOMA; OUTCOME ASSESSMENT; RECTUM CANCER; RETROSPECTIVE STUDY; VAGINA BLEEDING; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; NEOPLASM; STROKE;

AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84864328560     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0780-5     Document Type: Article

References (12)

1. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM (2004) Stroke in patients with cancer: incidence and etiology. Neurology 62:2025-2030
2. Oberndorfer S, Nussgruber V, Berger O, Lahrmann H, Grisold W (2009) Stroke in cancer patients: a risk factor analysis. J Neurooncol 94:221-226
3. Bushnell CD, Goldstein LB (2004) Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology 63:1230-1233
4. Barrett-Connor E, Cox DA, Song J, Mitlak B, Mosca L, Grady D (2009) Raloxifene and risk for stroke based on the Framingham stroke risk score. Am J Med 122:754-761
5. Seok JM, Kim SG, Kim JW et al (2010) Coagulopathy and embolic signals in cancer patients with ischemic stroke. Ann Neurol 68:213-219
6. Kim SG, Hong JM, Kim HY et al (2010) Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke 41:798-801
7. Mazokopakis EE, Syros PK, Starakis IK (2010) Nonbacterial thrombotic endocarditis (marantic endocarditis) in cancer patients. Cardiovasc Hematol Disord Drug Targets 10:84-86
8. Casado-Naranjo I, Calle ML, Falcon A, et al. (2011) Intravenous thrombolysis for acute stroke in patients with cancer. J Neurol Neurosurg Psychiatry 82:1404-1405
9. Masrur S, Abdullah AR, Smith ER et al (2011) Risk of thrombolysis for acute ischemic stroke in patients with current malignancy. J Stroke Cerebrovasc Dis 20:124-130
10. Mikkola KM, Patel SR, Parker JA et al (1997) Attenuation over 24 h of the efficacy of thrombolysis of pulmonary embolism among patients with cancer. Am Heart J 134:603-607
11. Adams HP, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 24:35-41
12. Dachs RJ, Burton JH, Joslin J (2008) A user's guide to the NINDS rt-PA stroke trial database. PLoS Med 5:e113